Stilla Technologies
keyboard_backspaceBack to Home
Contact
1 Mail du professeur Georges Mathé
94800 Villejuif
France
Sales Director
About us
Stilla Technologies is a French industrial company with a global presence, providing cutting-edge PCR solutions to biologists for the precise quantification of DNA and RNA.
Business offer
Stilla offers a comprehensive range of tests, services, and genetic analysis systems based on Digital PCR — the third generation of PCR technology, known for its superior accuracy, sensitivity and reproducibility versus PCR and qPCR.
Digital PCR has become a key technology for pharma, CRO, CDMO companies to ensure their products are developed and manufactured with the highest quality standards, while getting rid of classic PCR limitations (standard curves, inconsistency of results across departments, difficult quantification with precious material, limited multiplexing etc…) .
To answer these challenges and adapt to the product cycle development, Stilla has developed the Nio® system, an all-in-one digital PCR device delivering speed, sensitivity, and precision to quantify DNA & RNA.
With Nio® system and dPCR assays, R&D scientists, quality departments and manufacturing can all work together to ensure their products hit the market on time with no compromise on safety.
Activities
- Technology Supplier
- Genetic Diseases
- Oncology
- Hematology
- Infectiology
- CMC/analytical quality assessment, quality control
- Contaminants detection
- Target Identification
- Expression and pathway analysis of target
- quantification of target
- Research exploratory companion biomarkers
- Biomarker Identification
- Research exploratory Companion biomarkers
- Bioinformatics design
- Bioinformatics prediction & analysis
- Bioproduction/CMC/Analytical Quality Assessment, Quality Control
- Bioproduction
- Scale-Up
- Quality control
- Contaminants detection
